These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2381939)

  • 1. The use of N-ethyl-N-nitrosourea to produce mouse models for human phenylketonuria and hyperphenylalaninemia.
    McDonald JD; Bode VC; Dove WF; Shedlovsky A
    Prog Clin Biol Res; 1990; 340C():407-13. PubMed ID: 2381939
    [No Abstract]   [Full Text] [Related]  

  • 2. Mental retardation in a family with phenylketonuria and mild hyperphenylalaninemia.
    Cohen BE; Szeinberg A; Berman W; Aviad Y; Crispin M; Hirshorn N; Goland R
    Pediatrics; 1969 Nov; 44(5):655-60. PubMed ID: 5374976
    [No Abstract]   [Full Text] [Related]  

  • 3. A heteroallelic mutant mouse model: A new orthologue for human hyperphenylalaninemia.
    Sarkissian CN; Boulais DM; McDonald JD; Scriver CR
    Mol Genet Metab; 2000 Mar; 69(3):188-94. PubMed ID: 10767173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenylketonuria and hyperphenylalaninemia: clinico-genetic classification of 14 forms].
    Annenkov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):351-6. PubMed ID: 6720175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.
    Güttler F
    Acta Paediatr Scand Suppl; 1980; 280():1-80. PubMed ID: 7006308
    [No Abstract]   [Full Text] [Related]  

  • 6. hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis.
    Bode VC; McDonald JD; Guenet JL; Simon D
    Genetics; 1988 Feb; 118(2):299-305. PubMed ID: 3360305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
    Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
    J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the mouse phenylalanine hydroxylase mutation Pah(enu3).
    Haefele MJ; White G; McDonald JD
    Mol Genet Metab; 2001 Jan; 72(1):27-30. PubMed ID: 11161825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mutations at the mouse phenylalanine hydroxylase locus.
    McDonald JD; Charlton CK
    Genomics; 1997 Feb; 39(3):402-5. PubMed ID: 9119379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-ethyl-N-nitrosourea-based generation of mouse models for mutant G protein-coupled receptors.
    Grosse J; Tarnow P; Römpler H; Schneider B; Sedlmeier R; Huffstadt U; Korthaus D; Nehls M; Wattler S; Schöneberg T; Biebermann H; Augustin M
    Physiol Genomics; 2006 Aug; 26(3):209-17. PubMed ID: 16720677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse mutation sarcosinemia (sar) maps to chromosome 2 in a region homologous to human 9q33-q34.
    Brunialti AL; Harding CO; Wolff JA; Guénet JL
    Genomics; 1996 Aug; 36(1):182-4. PubMed ID: 8812433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperphenylalaninemia in the neonatal period].
    Spahr A
    Rev Med Suisse Romande; 1973 Sep; 93(9):679-86. PubMed ID: 4769047
    [No Abstract]   [Full Text] [Related]  

  • 13. Inborn errors of metabolism. Variability within single diseases.
    Danks DM
    Clin Pediatr (Phila); 1971 Jan; 10(1):1-3. PubMed ID: 5545904
    [No Abstract]   [Full Text] [Related]  

  • 14. A mouse model for human hereditary tyrosinemia I.
    Holdener BC; Magnuson T
    Bioessays; 1994 Feb; 16(2):85-7. PubMed ID: 8147847
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: frequent mutation allows screening and early diagnosis.
    Zschocke J; Graham CA; Stewart FJ; Carson DJ; Nevin NC
    Hum Mutat; 1994; 4(2):114-8. PubMed ID: 7981714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients.
    Guldberg P; Henriksen KF; Thöny B; Blau N; Güttler F
    Genomics; 1994 May; 21(2):453-5. PubMed ID: 8088845
    [No Abstract]   [Full Text] [Related]  

  • 17. Mendelian hyperphenylalaninemia.
    Scriver CR; Kaufman S; Woo SL
    Annu Rev Genet; 1988; 22():301-21. PubMed ID: 3071251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification and heterogeneity of hyperphenylalaninemias linked to a phenylalanine hydroxylase deficiency].
    Rey F; Munnich A; Lyonnet S; Rey J
    Arch Fr Pediatr; 1987; 44 Suppl 1():639-42. PubMed ID: 3329492
    [No Abstract]   [Full Text] [Related]  

  • 19. Facilitation of hyperphenylalaninaemia phenotype assessment by genotype analysis.
    Konecki DS; Schweitzer-Krantz S; Byrd D; Trefz FK; Lichter-Konecki U
    Eur J Pediatr; 1993 Dec; 152(12):1048-9. PubMed ID: 8131811
    [No Abstract]   [Full Text] [Related]  

  • 20. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.